A Rho-kinase inhibitor, soluble guanylate cyclase activator and nitric oxide-releasing PDE5 inhibitor: novel approaches to erectile dysfunction

Author： Cellek Selim   Rees Rowland W   Kalsi Jas  

Publisher： Informa Healthcare

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.11, Iss.11, 2002-11, pp. : 1563-1573

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Ambroxol as an inhibitor of nitric oxide-dependent activation of soluble guanylate cyclase

By Severina I.S.   Bussygina O.G.   Pyatakova N.V.   Khropov Y.V.   Krasnoperov R.A.  

European Journal of Pharmacology, Vol. 407, Iss. 1, 2000-10 ,pp. : 61-64

Elsevier

Access to resources Recommend Favorite

Activators of the nitric oxide sensor, soluble guanylate cyclase

By  

Expert Opinion on Therapeutic Patents, Vol. 10, Iss. 11, 2000-11 ,pp. : 1765-1770

Informa Healthcare

Access to resources Recommend Favorite

YC-1, a nitric oxide-independent activator of soluble guanylate cyclase, inhibits platelet-rich thrombosis in mice

By Teng C.-M.   Wu C.-C.   Ko F.-N.   Lee F.-Y.   Kuo S.-C.  

European Journal of Pharmacology, Vol. 320, Iss. 2, 1997-02 ,pp. : 161-166

Elsevier

Access to resources Recommend Favorite

Vardenafil: a novel type 5 phosphodiesterase inhibitor for the treatment of erectile dysfunction

By Kendirci Muammer   Bivalacqua Trinity J   Hellstrom Wayne JG  

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 4, 2004-04 ,pp. : 923-932

Informa Healthcare

Access to resources Recommend Favorite

Treatment for Erectile Dysfunction Based on Patient-Reported Outcomes: To Every Man the PDE5 Inhibitor that He Finds Superior

By Hedelin Hans   Ströberg Peter  

Drugs, Vol. 65, Iss. 16, 2005-01 ,pp. : 2245-2251

Adis International

Access to resources Recommend Favorite